Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Expanded use of Visudyne approved by Canadian authorities

July 30, 2001

New compounds from Alcon particularly useful for treatment of dry eye

July 18, 2001

Allergan claims new cyclopentane derivatives for glaucoma management

July 12, 2001

Ad-vIL-10 as a promising strategy for human uveitis

July 11, 2001

ISTA completes enrollment in second phase III study of Vitrase

July 6, 2001

Vernalis and Alcon enter glaucoma alliance

July 5, 2001

Allergan and Inspire collaborate on development of two ophthalmic products for dry eye

July 2, 2001

ISTA completes enrollment in phase III study of Vitrase

July 2, 2001

EntreMed and NEI study Panzem in age-related macular degeneration

June 26, 2001

Receptor subtype-selective muscarinic agonist compares favorably with pilocarpine in primates

June 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...